期刊文献+

左炔诺孕酮宫内缓释系统非避孕临床应用 被引量:11

Clinical Applications of Levonorgestrel-releasing Intrauterine System in Non-contraceptive Field
下载PDF
导出
摘要 左炔诺孕酮宫内缓释系统(LNG-IUS)是一个载有左炔诺孕酮储库的T型支架,主要在宫腔内发挥局部孕激素作用。LNG-IUS除提供长期有效且可逆的避孕作用外,在月经过多、激素替代治疗(HRT)的内膜保护方面也有确切疗效。另有研究表明,LNG-IUS在子宫内膜异位性疾病、子宫肌瘤、子宫内膜增生症等方面也有较好的治疗作用。放置LNG-IUS后最常见的不良反应是不规则阴道出血和发生良性卵巢囊肿。 LNG-IUS is a kind of T shaped stent that carries areservoir containing levonorgestrel,which mainly exhibits progestational activity in the uterine cavity.Besides providing long-term effective and reversible contraceptive effects,LNG-IUS also has definite effects in menorrhagia and endometrial protection during HRT.In addition,studies have shown that LNG-IUS also has favourable therapeutic effects in endometriosis,adenomyosis,uterine fibroids and endometrial hyperplasia,ect.The most common side effects of LNG-IUS are irregular vaginal bleeding and the occurrence of benign ovarian cysts.
出处 《国际生殖健康/计划生育杂志》 CAS 2010年第1期48-51,共4页 Journal of International Reproductive Health/Family Planning
关键词 左炔诺孕酮宫内缓释系统 月经过多 子宫内膜保护 子宫内膜异位性疾病 Levonorgestrel-releasing intrauterine system Menorrhagia Endometrial protection Endometriosis
  • 相关文献

参考文献21

  • 1Xiao B, Wu SC, Chong J, et al. Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia [J]. Fertil Steril, 2003, 79 (4): 963-969.
  • 2Kriplani A, Singh BM, Lal S, et al. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia[J]. Int J Gynecol Obstet, 2007, 97(3 ) : 190-194.
  • 3Milsom I. The levonorgestrel-releasing intrauterine system as an al- ternative to hysterectomy in peri-menopausal women[J]. Contracep- ~ . tion, 2007, 75(6): 152-154.
  • 4Kucuk T, Ertan K. Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a ran domized, prospective, controlled clinical trial in female smokers [J]. Clin Exp Obstet and Gynecol, 2008.35( 1 ):57-60.
  • 5Halmesmaki K, Hurskainen R, Teperi J, et al. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial [J]. B JOG, 2007, 114(5 ): 563-568,.
  • 6Boon J, Scholten PC, Oldenhave A, et al. Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT [J]. Maturitas, 2003, 46( 1 ): 69-77.
  • 7Hampton NR, Rees MC, Lowe DG, et al. Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women [J]. Hum Reprod, 2005, 20(9 ): 2653-2660.
  • 8Gardner FJ, Konje JC, Bell SC, et al. Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system iong-term follow-up of a randomised control trial [J]. Gynecol Oncol, 2009, 114(3 ): 452-456.
  • 9Kesim MD, Aydin Y, Atis A, et al. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen[J]. Climacteric, 2008, 11 (3):252-257.
  • 10Lockhat FB, Emembolu JE, Konje JC. The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease [J]. Hum Reprod, 2004, 19( 1 ): 179-184.

同被引文献86

引证文献11

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部